Results 61 to 70 of about 1,203 (203)
Dermatoses neutrofílicas: parte II Neutrophilic dermatoses: part II
Neste artigo são abordadas as dermatoses neutrofílicas, complementando o artigo anterior (parte I). São apresentadas e comentadas as seguintes dermatoses: pustulose subcórnea de Sneddon-Wilkinson, dermatite crural pustulosa e atrófica, pustulose ...
Fernanda Razera +2 more
doaj +1 more source
Acrodermatitis continua of Hallopeau and psoriatic arthritis: A case report [PDF]
A 44-year-old man, previously healthy, consulted for a three-month history of asymmetrical polyarthralgia with inflammatory features involving. small mod large joints.
Arellano Lorca, Javier +3 more
core +1 more source
Xianjie Yang,* Juan Wang,* Huan Wang, Minmin Kong, Qiquann Chen Department of Dermatology, Southwest Hospital, Army Medical University, Chongqing, People’s Republic of China*These authors contributed equally to this workCorrespondence ...
Yang X, Wang J, Wang H, Kong M, Chen Q
doaj
Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
Introduction: Apremilast, an oral phosphodiesterase-4 inhibitor, decreases the production of pro-inflammatory cytokines including tumour necrosis factor-α, interleukin-12/23, IL-12, IL-2, and interferon-γ; while upregulating the anti-inflammatory ...
Saurabh Bhatia
doaj +3 more sources
Autoinflammatory keratinization diseases [PDF]
ファイル公開:2018-12-01journal ...
76090 +7 more
core +5 more sources
Pustular Psoriasis: From Pathophysiology to Treatment
Pustular psoriasis (PP) is a clinicopathological entity encompassing different variants, i.e., acute generalized PP (GPP), PP of pregnancy (impetigo herpetiformis), annular (and circinate) PP, infantile/juvenile PP, palmoplantar PP/palmoplantar ...
Giovanni Genovese +5 more
doaj +1 more source
Apremilast as an Off-Label Therapeutic Agent [PDF]
Objective: To review the literature regarding the efficacy and safety of off-label use of apremilast in combination therapies for psoriasis and psoriatic arthritis and for other currently off-label inflammatory dermatoses.
Lebwohl, Mark, Marson, Justin
core +1 more source
Successful therapy of acrodermatitis continua of Hallopeau with IL‐23 blockers –two new cases
Acrodermatitis continua of Hallopeau (ACH) is a very rare inflammatory, often chronic pustular skin and nail bed disease of the distal phalanges, which can result in permanent anonychia and disfigurement of the distal phalanges.
N. Langer +4 more
semanticscholar +1 more source
Abstract Secukinumab is one of the human monoclonal antibodies recommended in the Japanese guidelines for patients with psoriasis, but few case reports and clinical studies on secukinumab for pustular psoriasis are available because of the rarity of the disease.
Ayako Fujishige, Noriko Seko
wiley +1 more source
Pyostomatitis vegetans : a review of the literature [PDF]
Pyostomatitis vegetans (PV) is a rare condition characterized by pustules that affect the oral mucosa. It is a highly specific marker for inflammatory bowel disease and its correct recognition may lead to the diagnosis of ulcerative colitis or Crohn?s ...
Buonaiuto, Curzio +5 more
core

